AI assistant
TOMPKINS FINANCIAL CORP — Director's Dealing 2012
Feb 15, 2012
32217_dirs_2012-02-15_6a7f0823-e00b-4d47-a185-5047a902c11a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: TOMPKINS FINANCIAL CORP (TMP)
CIK: 0001005817
Period of Report: 2011-12-31
Reporting Person: PAGE RICHARD W. (Sr. Vice President, CTO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-31 | Common Stock | L | 168 | — | Acquired | 2845 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy) | $37.2727 | 2017-11-29 | Common Stock (5500) | 5500 | Direct |
| Stock Appreciation Rights (SAR) | $41.7091 | 2019-09-17 | Common Stock (11000) | 11000 | Direct |
| Stock Appreciation Rights (SAR) | $37.00 | 2021-08-19 | Common Stock (5250) | 5250 | Direct |
Footnotes
F1: Shares acquired through profit sharing, 401K contributions and reinvestment of quarterly cash dividends.
F2: The option becomes exercisable in six annual installments commencing two years after the date of grant.
F3: Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.
F4: Includes 1,195 shares of TMP stock held in the reporting person's 401K/ESOP, 1,027 of which were previously reported as "Common Stock - 401K/ESOP" shares in Table I in the reporting person's Form 5 filed on February 15, 2011.
F5: Includes 1,650 shares of Restricted Stock granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. Restricted Stock grants have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. The grant will expire ten years from the date of the grant.